Mary PatGallagherMD

Clinical Trials

• TrialNet Pathway to Prevention of T1D Start of enrollment: 2004 Feb 01

  Recruiting

• New Onset of Type 1 Diabetes Mycophenolate Mofetil-Daclizumab Clinical Trial Start of enrollment: 2004 May 01

  Completed

  Phase 2

• Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials Start of enrollment: 2004 Nov 01

  Completed

  Not Applicable

• Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus Start of enrollment: 2007 Feb 01

  Completed

  Phase 3

• Intravenous CTLA4-lg Treatment in Recent Onset Type 1 Diabetes Mellitus Start of enrollment: 2008 Feb 01

  Completed

  Phase 2

• Study of Antithymocyte Globulin for Treatment of New-onset T1DM Start of enrollment: 2007 Aug 01

  Terminated

  Phase 2

• Proleukin and Rapamune in Type 1 Diabetes Start of enrollment: 2007 Aug 01

  Completed

  Phase 1

• Effects of Recombinant Human Glutamic Acid Decarboxylase on the Progression of Type 1 Diabetes in New Onset Subjects Start of enrollment: 2009 Feb 01

  Completed

  Phase 2

• Treatment With hOKT3gamma1(Ala-Ala) in T1DM Start of enrollment: 2002 May 01

  Terminated

  Phase 2

• Canakinumab Study in Individuals With Newly Diagnosed Type 1 Diabetes Start of enrollment: 2010 Oct 01

  Completed

  Phase 2

• Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk" Start of enrollment: 2010 Aug 01

  Completed

  Phase 2

• A Research Trial of Aralast NP in New Onset Diabetes (RETAIN) - Part II Start of enrollment: 2010 Oct 01

  Withdrawn

  Phase 2

• A Research Trial of Aralast in New Onset Diabetes (RETAIN) Start of enrollment: 2010 Oct 01

  Terminated

  Phase 1

• ATG-GCSF in New Onset Type 1 Diabetes Start of enrollment: 2014 Dec 01

  Completed

  Phase 2

• Tocilizumab (TCZ) in New-onset Type 1 Diabetes Start of enrollment: 2015 Mar 12

  Completed

  Phase 2

• Join now to see all